Research Institute of Molecular Pathology (IMP)

Research Institute of Molecular Pathology (IMP)

Forschung

A leading basic research institute addressing fundamental questions in molecular biology. Part of Vienna BioCenter.

Info

The Research Institute of Molecular Pathology (IMP) in Vienna is a basic biomedical research institute largely sponsored by Boehringer Ingelheim. With over 200 scientists from 40 countries, the IMP is committed to scientific discovery of fundamental molecular and cellular mechanisms underlying complex biological phenomena. Research areas include cell and molecular biology, microscopy, immunology and cancer, developmental biology, chromosome biology, and computational biology.

Website
http://www.imp.ac.at
Branche
Forschung
Größe
201–500 Beschäftigte
Hauptsitz
Vienna
Art
Einzelunternehmen (Gewerbe, Freiberufler etc.)
Gegründet
1985
Spezialgebiete
Molecular Biology, Disease Mechanisms, Computational biology, Immunology, Cell Biology, Chromosome Biology, Gene Regulation, Developmental Biology und Microscopy

Orte

Beschäftigte von Research Institute of Molecular Pathology (IMP)

Updates

Ähnliche Seiten